Why Cooper Companies Stock Sank by 13% Today

Cooper Companies (COO) shares sank 13% following its fiscal Q3 2025 earnings release, despite reporting revenue of $1.06 billion (up 6% YOY and in line with consensus) and non-GAAP adjusted EPS of $1.10 (slightly above estimates). The significant market reaction stemmed from unmet growth expectations, particularly within its leading CooperVision division, which recorded its lowest organic growth since the Great Recession, a point highlighted by analyst Jason Bednar and acknowledged by the company itself. Cooper also provided fiscal 2025 revenue guidance of $4.08-$4.1 billion and adjusted EPS of $4.08-$4.12.

Analysis

Cooper Companies (COO) experienced a significant 13% decline in its stock price, starkly underperforming the S&P 500, despite reporting fiscal third-quarter results that appeared to meet or beat consensus estimates. The company posted revenue of $1.06 billion, a 6% year-over-year increase, and a non-GAAP adjusted EPS of $1.10, which was 15% higher than the prior year and slightly above the $1.06 analyst forecast. The primary driver for the negative market sentiment was the performance of its largest division, CooperVision (CVI), which failed to meet investor growth expectations. Although CVI's revenue grew 6% to $718 million, its organic growth rate was reportedly the lowest since the Great Recession, a critical point of concern noted by Piper Sandler. While the company's full-year fiscal 2025 guidance projects revenue of $4.08-$4.1 billion and adjusted EPS of $4.08-$4.12, implying growth over fiscal 2024, the market has clearly priced in the immediate deceleration in its core business segment.

Key Decisions for Investors

• Investors should closely scrutinize the organic growth trajectory of the CooperVision division in the upcoming quarters, as its performance is the primary driver of current market sentiment.
• The 13% stock price decline warrants a re-evaluation of the company's valuation, but any potential entry should be heavily weighed against the risk of continued fundamental weakness in its core business.
• The viability of the company's full-year 2025 guidance for revenue and adjusted EPS is now a key factor to watch, as the market appears skeptical of management's ability to hit these targets given the Q3 slowdown.